These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29901068)

  • 21. PDZ binding kinase (PBK) is a theranostic target for nasopharyngeal carcinoma: driving tumor growth via ROS signaling and correlating with patient survival.
    Wang MY; Lin ZR; Cao Y; Zheng LS; Peng LX; Sun R; Meng DF; Xie P; Yang JP; Cao L; Xu L; Huang BJ; Qian CN
    Oncotarget; 2016 May; 7(18):26604-16. PubMed ID: 27049917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PBK/TOPK, a proliferating neural progenitor-specific mitogen-activated protein kinase kinase.
    Dougherty JD; Garcia AD; Nakano I; Livingstone M; Norris B; Polakiewicz R; Wexler EM; Sofroniew MV; Kornblum HI; Geschwind DH
    J Neurosci; 2005 Nov; 25(46):10773-85. PubMed ID: 16291951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of PBK/TOPK Contributes to Tumor Development and Poor Outcome of Esophageal Squamous Cell Carcinoma.
    Ohashi T; Komatsu S; Ichikawa D; Miyamae M; Okajima W; Imamura T; Kiuchi J; Nishibeppu K; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Anticancer Res; 2016 Dec; 36(12):6457-6466. PubMed ID: 27919968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PBK/TOPK is a novel mitotic kinase which is upregulated in Burkitt's lymphoma and other highly proliferative malignant cells.
    Simons-Evelyn M; Bailey-Dell K; Toretsky JA; Ross DD; Fenton R; Kalvakolanu D; Rapoport AP
    Blood Cells Mol Dis; 2001; 27(5):825-9. PubMed ID: 11783945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer.
    Park JH; Lin ML; Nishidate T; Nakamura Y; Katagiri T
    Cancer Res; 2006 Sep; 66(18):9186-95. PubMed ID: 16982762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of artesunate for the treatment of adult T-cell leukemia/lymphoma.
    Ishikawa C; Senba M; Mori N
    Eur J Pharmacol; 2020 Apr; 872():172953. PubMed ID: 31996318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of PDZ-binding kinase/T-LAK cell-originated protein kinase (PBK/TOPK) in human urinary bladder transitional cell carcinoma.
    Singh PK; Srivastava AK; Dalela D; Rath SK; Goel MM; Bhatt ML
    Immunobiology; 2014 Jun; 219(6):469-74. PubMed ID: 24629784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of the solar ultraviolet-induced skin carcinogenesis by TOPK inhibitor HI-TOPK-032.
    Roh E; Han Y; Reddy K; Zykova TA; Lee MH; Yao K; Bai R; Curiel-Lewandrowski C; Dong Z
    Oncogene; 2020 May; 39(21):4170-4182. PubMed ID: 32277233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphorylation of IκBα at serine 32 by T-lymphokine-activated killer cell-originated protein kinase is essential for chemoresistance against doxorubicin in cervical cancer cells.
    Park JH; Yoon DS; Choi HJ; Hahm DH; Oh SM
    J Biol Chem; 2013 Feb; 288(5):3585-93. PubMed ID: 23250755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Protective Role of the TOPK/PBK Pathway in Myocardial Ischemia/Reperfusion and H₂O₂-Induced Injury in H9C2 Cardiomyocytes.
    Sun G; Ye N; Dai D; Chen Y; Li C; Sun Y
    Int J Mol Sci; 2016 Feb; 17(3):267. PubMed ID: 26907268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PBK/TOPK Expression Predicts Prognosis in Oral Cancer.
    Chang CF; Chen SL; Sung WW; Hsieh MJ; Hsu HT; Chen LH; Chen MK; Ko JL; Chen CJ; Chou MC
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PDZ-binding kinase/T-LAK cell-originated protein kinase is a target of the fucoidan from brown alga Fucus evanescens in the prevention of EGF-induced neoplastic cell transformation and colon cancer growth.
    Vishchuk OS; Sun H; Wang Z; Ermakova SP; Xiao J; Lu T; Xue P; Zvyagintseva TN; Xiong H; Shao C; Yan W; Duan Q; Zhu F
    Oncotarget; 2016 Apr; 7(14):18763-73. PubMed ID: 26936995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel selective TOPK inhibitor SKLB-C05 inhibits colorectal carcinoma growth and metastasis.
    Gao T; Hu Q; Hu X; Lei Q; Feng Z; Yu X; Peng C; Song X; He H; Xu Y; Zuo W; Zeng J; Liu Z; Yu L
    Cancer Lett; 2019 Mar; 445():11-23. PubMed ID: 30590102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potent anti-myeloma activity of the TOPK inhibitor OTS514 in pre-clinical models.
    Stefka AT; Johnson D; Rosebeck S; Park JH; Nakamura Y; Jakubowiak AJ
    Cancer Med; 2020 Jan; 9(1):324-334. PubMed ID: 31714026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A mitotic kinase TOPK enhances Cdk1/cyclin B1-dependent phosphorylation of PRC1 and promotes cytokinesis.
    Abe Y; Takeuchi T; Kagawa-Miki L; Ueda N; Shigemoto K; Yasukawa M; Kito K
    J Mol Biol; 2007 Jul; 370(2):231-45. PubMed ID: 17512944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PBK/TOPK in the differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma and its involvement in prognosis of human cholangiocarcinoma.
    He F; Yan Q; Fan L; Liu Y; Cui J; Wang J; Wang L; Wang Y; Wang Z; Guo Y; Huang G
    Hum Pathol; 2010 Mar; 41(3):415-24. PubMed ID: 19954816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of TOPK by lipopolysaccharide promotes induction of inducible nitric oxide synthase through NF-κB activity in leukemia cells.
    Park JH; Jeong YJ; Won HK; Choi SY; Park JH; Oh SM
    Cell Signal; 2014 May; 26(5):849-56. PubMed ID: 24440499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-216b promotes cell growth and enhances chemosensitivity of colorectal cancer by suppressing PDZ-binding kinase.
    Zou J; Kuang W; Hu J; Rao H
    Biochem Biophys Res Commun; 2017 Jun; 488(2):247-252. PubMed ID: 28373071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-216b-3p inhibits lung adenocarcinoma cell growth via regulating PDZ binding kinase/T-LAK-cell-originated protein kinase.
    Chai Y; Xue H; Wu Y; Du X; Zhang Z; Zhang Y; Zhang L; Zhang S; Zhang Z; Xue Z
    Exp Ther Med; 2018 Jun; 15(6):4822-4828. PubMed ID: 29805502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TOPK and PTEN participate in CHFR mediated mitotic checkpoint.
    Shinde SR; Gangula NR; Kavela S; Pandey V; Maddika S
    Cell Signal; 2013 Dec; 25(12):2511-7. PubMed ID: 24012691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.